Number of subjects (n) | 17 |
Male / Female | 10 (58.8%) / 7 (41.2%) |
Early AD (MCI due to AD / mild dementia due to AD) | 9 (52.9%) / 8 (47.1%) |
Mean ± SD (Min – Max) | |
Age at BL [years] | 66.76 ± 6.34 (55–77) |
Time to follow-up [months] | 26.59 ± 2.21 (23–30) |
CDR-global (BL) | 0.70 ± 0.25 (0.5–1) |
ΔCDR-global after 24 months | 0.46 ± 0.51 (0.5–2) |
CDR-SOB (BL) | 4.09 ± 2.12 (0.50–9.00) |
ΔCDR-SOB after 24 months | 2.29 ± 2.74 (− 2.09–6.92) |
MMSE (BL) | 23.65 ± 3.39 (16–28) |
ΔMMSE within 24 months | −4.64 ± 4.59 (− 13.33–2.88) |
ApoE ε4 allele carrier status Homozygous/ heterozygous/ non-carrier | 3 / 8 / 6 |